99.5% up by HPLC Salcaprozate sodium/SNAC 203787-91-1

Category:Active Pharmaceutical Ingredients > Other Active Pharmaceutical Ingredients
Product Name:99.5% up by HPLC Salcaprozate sodium/SNAC 203787-91-1
CAS No.:203787-91-1
Standard:ChP
Price(USD):Negotiable
Company:Sinoway Industrial Co. Ltd

Basic Info
  • Grade: Pharmaceutical Grade

    Factory Location: Xiamen

    Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa

  • Monthly Production Capacity: 10tons/year

    Contract Manufacturing: CRO,CMO

    Packaging Information: 25kg/bag

  • Delivery Lead Time: 7 days after payment

    Sample Provided: yes

    Payment Terms: L/C

      

    Product Information

     

    Product name

    Salcaprozate sodium;

    SNAC;

    sodium,8-[(2-hydroxybenzoyl)amino]octanoate

    CAS No.

    203787-91-1

    Molecular Formula

    C15H22NNaO4

    Molecular Weight

    303.33

    Quality Standard

    99.5% up by HPLC, US-DMF

    Appearance

    White to off-white powder

     

    COA

     

    Test Items

    Specifications

    Results

    Appearance

    White to off-white powder

    Off-white powder

    pH

    6.5-8.5

    7.5

    Humidification

    Extremely humidifying

    Conforms

     

     

     

    Identification

    The retention time of the main peak of the test solution

    should be consistent with the retention time of the main

    peak of the reference solution

    Conforms

    IR spectrum corresponds to that of the reference standard

    Conforms

    Solubility

    Freely soluble in methanol and water, soluble in 1-methyl-2-pyrrolidone, slightly soluble in ethanol, almost

    insoluble or insoluble in isopropanol

    Conforms

    Sodium ion content

    7.17%-8.09%

    7.58%

    Water

    2.0%

    0.95%

    Related substances I

    SAL-02

     0.1%

    Not detected

    SAL-SM1

     0.1%

    Not detected

    SAL-01

     0.1%

    Not detected

    SAL-03-B

     0.1%

    Not detected

    SAL-03-F

     0.1%

    Not detected

    SAL-02-C

     0.1%

    0.02%

    Any single unspecified

     0.1%

    0.02%

    Total impurities

     1.0%

    0.06%

    Related substances II

    HEDTA

     0.1%

    Not detected

    Residual solvents I

    Methanol

     0.3%

    Not detected

    Ethanol

     0.5%

    Not detected

    N-heptane

     0.5%

    0.0005%

    Ethyl acetate

     0.5%

    Not detected

    Dimethyl carbonate

     0.1%

    Not detected

    Isopropanol

     0.5%

    0.01%

    N,N-dimethylformamide

     0.088%

    Not detected

    Residual solvents II

    Methyl Chloride

     0.0005%

    Not detected

    Ethyl Chloride

     0.0005%

    Not detected

    Benzene

     0.0002%

    Not detected

    Assay

    97.0% -103.0% of C15H20NNaO4. calculated on the dried basis.

    100.1%

    Microbial Limit

    Total aerobic microbial count

     1000 cfu/g

    < 10cfu/g

    Total yeasts and molds count

     100 cfu/g

    10cfu/g

    Conclusion

    The product complies with the In-house specification

     

    Usage

     

    Salcaprozate Sodium (SNAC)

     

    SNAC (salcaprozate sodium) is a clinically validated oral absorption enhancer designed to improve the bioavailability of peptide drugs such as semaglutide (Rybelsus®). Its dual-action mechanism includes:

     

    1. ‌Enhanced Lipophilicity and Permeability

    By forming ‌non-covalent complexes‌ with macromolecules (e.g., insulin, heparin, GLP-1 agonists), SNAC increases drug lipophilicity, facilitating passive transcellular transport across intestinal epithelial cells. This process reduces gastric acid/enzyme degradation and enhances intestinal absorption efficiency.

    2. ‌Gastric Environment Modulation

    SNAC transiently elevates gastric pH, suppresses pepsin activity, and stabilizes drugs in monomeric forms to optimize permeability.

    3. ‌Key Applications

    (1)‌Semaglutide Formulations‌: Critical for oral Rybelsus® production, SNAC enables >0.5% bioavailability (vs. <0.01% without enhancers)

    (2)‌Insulin/Heparin Delivery‌: Reduces degradation rates by >70% and extends plasma half-life

     

    SNAC’s unique profile positions it as a cornerstone excipient for next-generation oral biologics, with validated safety and formulation flexibility.

     

      

Send your message to this supplier
  • From:
  • To:
    Sinoway Industrial Co. Ltd
  • Send a Copy to this Email
  • Message:
    Upload Images / Files
    - Supports jpg, jpeg, png,
     gif, pdf, doc, docx,
     xls, xlsx, txt, rar and zip
    - Max upload 3 files;
     Max  total size: 3MB
    (0/3)

    Enter between 20 to 4,000 characters.This is not what you are looking for ? Post a Sourcing Request Now

  • Verification:
PharmaSources Customer Service